Key result
In primary and secondary prevention ICD patients with private driving habits, the annual risk of harm to others remains below the acceptable cut-off of 5 per 100,000 directly following implantation or an inappropriate shock, but driving should be restricted for 4 and 2 months, respectively, following an appropriate shock.
Why the study?
What are the appropriate driving restrictions for primary and secondary prevention ICD patients following implantation or shocks based on the risk of harm to others?
Observational (n=2,786)
No
What are the appropriate driving restrictions for primary and secondary prevention ICD patients following implantation or shocks based on the risk of harm to others?
This analysis provides an evidence-based framework for driving restrictions after ICD implantation, recommending temporary restrictions for private drivers only after appropriate shocks and permanent restrictions for all professional drivers.
Answers are grounded in this paper and cite their sources.
Supports restricting private driving 2-4 months after appropriate ICD shocks; leaves open need for prospective validation of risk thresholds.
AIMS: Little evidence is available regarding restrictions from driving following implantable cardioverter defibrillator (ICD) implantation or following first appropriate or inappropriate shock. The purpose of the current analysis was to provide evidence for driving restrictions based on real-world incidences of shocks (appropriate and inappropriate). METHODS AND RESULTS: A total of 2786 primary and secondary prevention ICD patients were included. The occurrence of shocks was noted during a median follow-up of 996 days (inter-quartile range, 428-1833 days). With the risk of harm (RH) formula, using the incidence of sudden cardiac incapacitation, the annual RH to others posed by a driver with an ICD was calculated. Based on Canadian data, the annual RH to others of 5 in 100 000 (0.005%) was used as a cut-off value. In both primary and secondary prevention ICD patients with private driving habits, no restrictions to drive directly following implantation, or an inappropriate shock are warranted. However, following an appropriate shock, these patients are at an increased risk to cause harm to other road users and therefore should be restricted to drive for a period of 2 and 4 months, respectively. In addition, all ICD patients with professional driving habits have a substantial elevated risk to cause harm to other road users during the complete follow-up after both implantation and shock and should therefore be restricted to drive permanently. CONCLUSION: The current analysis provides a clinically applicable tool for guideline committees to establish evidence-based driving restrictions.
No takes yet. Share an insight, caveat, or question.
Thijssen et al. (2011) conducted an observational in Primary and secondary prevention implantable cardioverter defibrillator (ICD) patients (n=2,786). ICD implantation was evaluated on First shock (appropriate or inappropriate). In primary and secondary prevention ICD patients with private driving habits, the annual risk of harm to others remains below the acceptable cut-off of 5 per 100,000 directly following implantation or an inappropriate shock, but driving should be restricted for 4 and 2 months, respectively, following an appropriate shock.
Synapse has enriched 10 related papers. Consider them for comparative context: